Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): A final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

TY - JOUR

T1 - Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21)

T2 - A final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

AU - The SOLO2/ENGOT-Ov21 Investigators

AU - Poveda, Andrés

AU - Floquet, Anne

AU - Ledermann, Jonathan A.

AU - Asher, Rebecca

AU - Penson, Richard T.

AU - Oza, Amit M.

AU - Korach, Jacob

AU - Huzarski, Tomasz

AU - Pignata, Sandro

AU - Friedlander, Michael

AU - Baldoni, Alessandra

AU - Park-Simon, Tjoung Won

AU - Tamura, Kenji

AU - Sonke, Gabe S.

AU - Lisyanskaya, Alla

AU - Kim, Jae Hoon

AU - Filho, Elias Abdo

AU - Milenkova, Tsveta

AU - Lowe, Elizabeth S.

AU - Rowe, Phil

AU - Vergote, Ignace

AU - Pujade-Lauraine, Eric

PY - 2021/9/1

Y1 - 2021/9/1

UR - http://www.scopus.com/inward/record.url?scp=85117201236&partnerID=8YFLogxK

U2 - 10.1097/OGX.0000000000000962

DO - 10.1097/OGX.0000000000000962

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

AN - SCOPUS:85117201236

SN - 0029-7828

VL - 76

SP - 535

EP - 536

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 9

ER -